) shares rose 1.8% in early New York trading on Wednesday after the company reported third-quarter results that topped analyst expectations.
In terms of specific product revenues, Biogen reported $1.16 billion in revenue for multiple sclerosis, in line with the estimate. Revenue for Spinraza reached $448.2 million, exceeding the estimate of $434.9 million.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Biogen Reports Earnings Wednesday. Here's What to Expect.Wall Street will likely be more interested in updates on future developments, rather than the latest quarter's numbers.
Lire la suite »